Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-18

FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for sulfasalazine from Sunrise Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

SUPPL AP for SULFASALAZINE (SULFASALAZINE)